These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30098162)

  • 1. Association of Fellow Eye With Study Eye Disease Trajectories and Need for Fellow Eye Treatment in Collaborative Initial Glaucoma Treatment Study (CIGTS) Participants.
    Niziol LM; Gillespie BW; Musch DC
    JAMA Ophthalmol; 2018 Oct; 136(10):1149-1156. PubMed ID: 30098162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.
    Musch DC; Gillespie BW; Niziol LM; Lichter PR; Varma R;
    Ophthalmology; 2011 Sep; 118(9):1766-73. PubMed ID: 21600658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
    Musch DC; Gillespie BW; Lichter PR; Niziol LM; Janz NK;
    Ophthalmology; 2009 Feb; 116(2):200-7. PubMed ID: 19019444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the collaborative initial glaucoma treatment study.
    Radcliffe NM; Musch DC; Niziol LM; Liebmann JM; Ritch R;
    Ophthalmology; 2010 Nov; 117(11):2055-60. PubMed ID: 20570363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist.
    Musch DC; Tarver ME; Goren MJ; Janz NK
    JAMA Ophthalmol; 2017 Dec; 135(12):1345-1351. PubMed ID: 29098286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
    Newman-Casey PA; Niziol LM; Gillespie BW; Janz NK; Lichter PR; Musch DC
    Ophthalmology; 2020 Apr; 127(4):477-483. PubMed ID: 31932093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods.
    Kazemian P; Lavieri MS; Van Oyen MP; Andrews C; Stein JD
    Ophthalmology; 2018 Apr; 125(4):569-577. PubMed ID: 29203067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual field improvement in the collaborative initial glaucoma treatment study.
    Musch DC; Gillespie BW; Palmberg PF; Spaeth G; Niziol LM; Lichter PR
    Am J Ophthalmol; 2014 Jul; 158(1):96-104.e2. PubMed ID: 24727262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study.
    Musch DC; Gillespie BW; Niziol LM; Cashwell LF; Lichter PR;
    Ophthalmology; 2008 Jun; 115(6):927-33. PubMed ID: 17964655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refusal of Trabeculectomy for the Fellow Eye in Collaborative Initial Glaucoma Treatment Study (CIGTS) Participants.
    Gupta D; Musch DC; Niziol LM; Chen PP
    Am J Ophthalmol; 2016 Jun; 166():1-7. PubMed ID: 27013068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma.
    De Moraes CG; Mansouri K; Liebmann JM; Ritch R;
    JAMA Ophthalmol; 2018 Jul; 136(7):779-785. PubMed ID: 29800011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Characteristics of Participants in the Treatment of Advanced Glaucoma Study: A Multicenter Randomized Controlled Trial.
    King AJ; Hudson J; Fernie G; Burr J; Azuara-Blanco A; Sparrow JM; Barton K; Garway-Heath DF; Kernohan A; MacLennan G;
    Am J Ophthalmol; 2020 May; 213():186-194. PubMed ID: 32006484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.
    Lichter PR; Musch DC; Gillespie BW; Guire KE; Janz NK; Wren PA; Mills RP;
    Ophthalmology; 2001 Nov; 108(11):1943-53. PubMed ID: 11713061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability.
    Gillespie BW; Musch DC; Guire KE; Mills RP; Lichter PR; Janz NK; Wren PA;
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2613-20. PubMed ID: 12766064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study.
    King AJ; Hudson J; Azuara-Blanco A; Burr J; Kernohan A; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; Davidson T; Vale L; MacLennan G;
    Ophthalmology; 2024 Jul; 131(7):759-770. PubMed ID: 38199528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
    Takihara Y; Inatani M; Ogata-Iwao M; Kawai M; Inoue T; Iwao K; Tanihara H
    JAMA Ophthalmol; 2014 Jan; 132(1):69-76. PubMed ID: 24232829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.